AbbVie Pushes Greater Flexibility With Oral Migraine Preventative Atogepant

 
• By Joseph Haas
  
Diagnosis - Migraine. Medical Concept with Red Pills, Injections and Syringe. Selective Focus. 3D Render.
AbbVie hopes it will have a third approved migraine therapy by year's end

More from Strategy

More from Business